Recursion Pharmaceuticals Inc vs Weibo Corp — how do they compare? Recursion Pharmaceuticals Inc trades at $3.35 (market cap $1.81B), while Weibo Corp trades at $7.77 (market cap $1.93B). The key difference: Recursion Pharmaceuticals Inc and Weibo Corp are close in size by market cap, and Weibo Corp pays a 7.75% dividend while Recursion Pharmaceuticals Inc pays none. Which is the better fit depends on your goals.
| RXRX | WB | |
|---|---|---|
Market Cap | $1.81B | $1.93B |
Sector | Health | Media |
52-Week High | $6.79 | $12.83 |
52-Week Low | $2.84 | $7.20 |
Enterprise Value | $1.33B | $1.20B |
Dividend Yield | — | 7.75% |
Trailing returns across standard periods
Latest headlines on both assets
Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company leveraging artificial intelligence (AI) and machine learning to industrialize drug discovery. The company's unique approach combines one of the world's largest biological and chemical datasets with automated wet-lab and computational systems to map human biology and identify potential therapeutic candidates across a range of diseases, including oncology and rare diseases. Recursion aims to accelerate the traditionally slow and expensive process of drug development.
Read more on RXRX →Weibo is the largest social media platform in China. As of 2020, Weibo had 521 million monthly active users and 225 million daily active users, many of whom are drawn there by the millions of key opinion leaders in entertainment, sports, and business circles. Sina is the major shareholder, holding 44.7% of shares and with 70.8% voting power.
Read more on WB →